MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

Anika Therapeutics, Inc. (ANIK)

Anika Therapeutics, Inc. (ANIK)

|||

Balance Sheets Overview

Current Ratio
447.87%
Quick Ratio
318.89%
Cash Ratio
173.44%
Unit: Thousand (K) dollars
Assets Breakdown
    • Cash and cash equivalents
    • Inventories
    • Right-of-use assets
    • Others
Liabilities Breakdown
    • Additional paid-in-capital
    • Retained earnings
    • Lease liabilities
    • Others
Balance Sheets
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Cash and cash equivalents
38,412
41,020
57,481
57,990
Accounts receivable, net
29,062
25,768
23,690
22,187
Inventories
28,565
22,838
18,787
16,284
Prepaid expenses and other current assets
3,151
3,935
3,400
5,129
Current assets held for sale
-
-
0
0
Total current assets
99,190
93,561
103,358
101,590
Property and equipment, net
40,102
39,722
40,324
40,684
Right-of-use assets
24,949
25,430
25,939
24,226
Other long-term assets
3,023
4,303
4,034
5,507
Notes receivable
5,718
5,679
5,636
6,478
Deferred tax assets
1,017
1,150
1,275
1,251
Intangible assets, net
1,650
1,650
1,650
1,650
Goodwill
7,825
7,892
8,054
8,051
Non-current assets held for sale
-
-
0
0
Total assets
183,474
179,387
190,270
189,437
Accounts payable
6,236
6,339
6,041
4,732
Accrued expenses and other current liabilities
15,911
14,627
15,867
14,357
Current liabilities held for sale
-
-
0
0
Total current liabilities
22,147
20,966
21,908
19,089
Other long-term liabilities
730
726
701
761
Lease liabilities
23,315
23,794
24,196
22,782
Non-current liabilities held for sale
-
-
0
0
Common stock, 0.01 par value 90,000 shares authorized, 15,711 issued and 13,383 outstanding and 15,385 issued and 13,889 outstanding at june 30, 2026 and december 31, 2025, respectively
134
133
139
144
Additional paid-in-capital
83,437
83,347
87,498
91,105
Accumulated other comprehensive loss
-5,329
-5,310
-4,959
-4,939
Retained earnings
59,040
55,731
60,787
60,495
Total stockholders equity
137,282
133,901
143,465
146,805
Total liabilities and stockholders equity
183,474
179,387
190,270
189,437
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Cash and cashequivalents$38,412K (-27.75%↓ Y/Y)Accounts receivable, net$29,062K (21.32%↑ Y/Y)Inventories$28,565K (68.80%↑ Y/Y)Prepaid expenses andother current assets$3,151K (-40.24%↓ Y/Y)Total current assets$99,190K (-0.13%↓ Y/Y)Property and equipment,net$40,102K (-2.39%↓ Y/Y)Right-of-use assets$24,949K (0.92%↑ Y/Y)Goodwill$7,825K (-2.87%↓ Y/Y)Notes receivable$5,718K (-5.32%↓ Y/Y)Other long-termassets$3,023K (-45.53%↓ Y/Y)Intangible assets, net$1,650K (-0.66%↓ Y/Y)Deferred tax assets$1,017K (-18.90%↓ Y/Y)Total assets$183,474K (-2.24%↓ Y/Y)Total liabilities andstockholders equity$183,474K (-2.24%↓ Y/Y)Total stockholdersequity$137,282K (-7.04%↓ Y/Y)Lease liabilities$23,315K (0.61%↑ Y/Y)Total currentliabilities$22,147K (37.72%↑ Y/Y)Other long-termliabilities$730K (-3.44%↓ Y/Y)Accumulated othercomprehensive loss-$5,329K (-12.07%↓ Y/Y)Additionalpaid-in-capital$83,437K (-6.73%↓ Y/Y)Retained earnings$59,040K (-6.02%↓ Y/Y)Accrued expenses andother current...$15,911K (40.68%↑ Y/Y)Accounts payable$6,236K (30.71%↑ Y/Y)Common stock, 0.01 parvalue 90,000 shares...$134K (-6.94%↓ Y/Y)